Many health technology assessment committees have an explicit or implicit reference value
(often referred to as a 'threshold') below which new health technologies or interventions are …

Background What constitutes innovation in health technologies can be defined and
measured in a number of ways and it has been widely researched and published about …

Like most of the world, low-and middle-income countries have faced a growing demand for
new health technologies and higher budget constraints. It is necessary to have technical …

Objectives Health technology assessment (HTA) uses evidence appraisal and synthesis
with economic evaluation to inform adoption decisions. Standard HTA processes sometimes …

There is growing interest in cost-effectiveness thresholds as a tool to inform resource
allocation decisions in health care. Studies from several countries have sought to estimate …

In the past two decades, most high-income countries have reduced their hospital bed
capacity. This could be a sign of increased efficiency but could also reflect a degradation in …

New technologies, including pharmaceuticals and medical devices, can improve treatment
options in healthcare but also bring concerns about rising healthcare costs. We undertake a …

BACKGROUND Economic evaluations provide evidence on whether or not digital
interventions offer value for money, based on their costs and outcomes relative to the costs …

Background In the UK, around 93,000 (0.8%) children and young people (CYP) are
experiencing specific phobias that have a substantial impact on daily life. The current gold …

Enhanced quadrivalent influenza vaccines that include an adjuvant (aQIV) or a high dose of
antigen (QIV-HD), which stimulate a stronger immune response in older adults than the …